You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifapentine

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Seropositivity, Tuberculosis, Household Contact Trial in Klerksdorp (Daily rifapentine and isoniazid for 4 weeks, Weekly

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Daily rifapentine and isoniazid for 4 weeks
  • Weekly rifapentine and isoniazid for 12 weeks
  • Klerksdorp, North West Province, South Africa
    The Aurum Institute: Gavin J Churchyard Legacy Centre
Jan 31, 2023

HIV Seropositivity, Pregnancy, Tuberculosis Infection Trial in Tembisa (Rifapentine, Isoniazid)

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Tembisa, Gauteng, South Africa
    The Aurum Institute: Tembisa Clinical Research Centre
Dec 9, 2022

Healthy Volunteers Trial run by the CC (Vemlidy (tenofivir alafenamide), Priftin (rifapentine), Isoniazid)

Recruiting
  • Healthy Volunteers
  • Vemlidy (tenofivir alafenamide)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 27, 2022

Tuberculosis, HIV Trial (Dolutegravir, 3HP)

Not yet recruiting
  • Tuberculosis
  • HIV
  • (no location specified)
Dec 9, 2022

Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Short Regimen with Rifapentine 10mg/kg
  • +3 more
  • Guiyang, Guizhou, China
  • +5 more
May 28, 2022

HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,

Not yet recruiting
  • HIV-associated Tuberculosis
  • Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
  • +3 more
  • Mowbray, Cape Town, Western Cape, South Africa
  • +3 more
Nov 18, 2022

Tuberculosis, Latent Tuberculosis, HIV/AIDS Trial in Kampala (Streamlined weekly DOT visits, Weekly DOT visit reminders, Cost

Active, not recruiting
  • Tuberculosis
  • +2 more
  • Streamlined weekly DOT visits
  • +5 more
  • Kampala, Uganda
    Mulago Immune Suppression Syndrome (ISS) Clinic
Nov 28, 2022

Tuberculosis, Hiv Trial in New Haven (Rifapentine daily, Rifapentine weekly)

Withdrawn
  • Tuberculosis
  • Hiv
  • Rifapentine daily
  • Rifapentine weekly
  • New Haven, Connecticut
    Yale New Haven Hospital
Sep 13, 2021

Tuberculosis Trial in Manaus, Rio De Janeiro (Rifapentine 600 mg and INH 300 mg, Rifapentine 900 mg and INH 900 mg)

Recruiting
  • Tuberculosis
  • Rifapentine 600 mg and INH 300 mg
  • Rifapentine 900 mg and INH 900 mg
  • Manaus, AM, Brazil
  • +1 more
Apr 14, 2022

Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)

Recruiting
  • Latent Tuberculosis Infection
  • isoniazid and rifapentine
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2022

Tuberculosis, Latent Tuberculosis Trial in Shanghai (Rifampin and Isoniazid, isoniazid and rifapentine)

Not yet recruiting
  • Tuberculosis
  • Latent Tuberculosis
  • Rifampin and Isoniazid
  • isoniazid and rifapentine
  • Shanghai, Shanghai, China
    Central Hospital of Jingan District
Aug 28, 2023

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

Completed
  • HIV Infected Population With Latent Tuberculosis
  • rifapentene (RPT)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 15, 2022

Tuberculosis Trial in United States (Rifapentine (RPT))

Completed
  • Tuberculosis
  • Rifapentine (RPT)
  • San Diego, California
  • +3 more
Nov 4, 2021

HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4

Recruiting
  • HIV-infected Participants With Latent TB Infection in High TB Burden Country
  • Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
  • Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
  • Bangkok, Thailand
  • +15 more
Mar 22, 2022

Tuberculosis Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (vitamin B6))

Completed
Has Results
  • Tuberculosis
  • Rifapentine (RPT)
  • +2 more
  • Port-au-Prince, Haiti
  • +4 more
Nov 2, 2021

Opioid Dependence, Addiction, HIV/AIDS Trial in Kajang (Buprenorphine Naloxone, Methadone, Isoniazid)

Recruiting
  • Opioid Dependence
  • +4 more
  • Buprenorphine Naloxone
  • +3 more
  • Kajang, Selangor, Malaysia
    Kajang Prison
May 18, 2022

Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney Trial in New Brunswick (Rifapentine)

Not yet recruiting
  • Latent Tuberculosis
  • +3 more
  • Rifapentine
  • New Brunswick, New Jersey
    Pinki J Bhatt
Jun 6, 2022

Compliance, Patient Trial in Aarhus, Esbjerg (Rifapentine, Isoniazid)

Recruiting
  • Compliance, Patient
  • Aarhus, Denmark
  • +1 more
Jul 26, 2021

Latent Tuberculosis, Kidney Failure Trial (Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone)

Not yet recruiting
  • Latent Tuberculosis
  • Kidney Failure
  • Rifampicin plus Isoniazid
  • +2 more
  • (no location specified)
Aug 24, 2021

Respiratory Tract Infections, HIV Trial in Tembisa (3HP plus DTG +2NRTIs)

Recruiting
  • Respiratory Tract Infections
  • HIV Infections
  • 3HP plus DTG +2NRTIs
  • Tembisa, Gauteng, South Africa
    The Aurum Institute: Tembisa Clinical Research Centre
Sep 7, 2021

Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • 4-month rifapentine-based regimen
  • Kaohsiung, Taiwan
  • +3 more
Apr 22, 2021

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
Has Results
  • Tuberculosis
  • rifapentine
  • +2 more
  • San Francisco, California
  • +32 more
Sep 1, 2021

Infertility, Female, Recurrent Implantation Failure, Genital Tuberculoses, Female Trial in Shanghai (rifapentine plus isoniazid)

Not yet recruiting
  • Infertility, Female
  • +3 more
  • rifapentine plus isoniazid
  • Shanghai, Shanghai, China
    Shanghai First Maternity and Infant Hospital
Aug 26, 2020

Silicosis, Tuberculosis Trial in Taizhou (Weekly INH / RRT given by DOT)

Completed
  • Silicosis
  • Tuberculosis
  • Weekly INH / RRT given by DOT
  • Taizhou, Zhejiang, China
    Wenling No.1 People's Hospital, Zhejiang
Jun 27, 2020